Occam Places Chief Legal Officer at Public Obesity Biotech, Metsera
Metsera (Nasdaq: MTSR) is a clinical-stage biotech focused on developing the next generation of medicines for obesity and metabolic disease. In May 2025, Occam placed Matt Lang as its Chief Legal Officer & Corporate Secretary.
Prior to Metsera, Matt had a multidimensional business career culminating in his service as Chief Business & Legal Officer of the public, clinical-stage cell therapy biotech, Lyell Immunopharma. He came to Lyell from Myovant, where he strategically built the legal and administrative functions of the company and guided the organization through its $2.9B acquisition by Sumitomo Pharma.
A classics major as an undergrad, Matt also received his JD from the University of Pennsylvania.
Related Placements
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.